Be with You - Breast Cancer Patient Support Program

CUHK Medical Centre (CUHKMC) partners with Roche Hong Kong Limited (Roche) to launch “Be with You - Breast Cancer Patient Support Program” (Program). While the Program is CUHKMC's first medicinal patient support program, it is among many other Roche’s patient support programs in Hong Kong which are operated through the partnering between other non-profit-making organisations, patient support groups and healthcare organisations with other medical practitioners to support patients in need.

The Program, jointly supported by CUHKMC and Roche, is launched in November 2022 for a period of three years. Breast cancer patients who are suitable to use the targeted therapy drugs listed in the program, and who meet the required financial condition, are eligible to participate. The degree of support is subject to the treatment plan and patient’s financial status. 


For program details, please refer to the website: 

CUHK Medical Centre (CUHKMC) is a non-profit, private teaching hospital wholly owned by The Chinese University of Hong Kong (CUHK). With a social mission to bridge the service gap between the public and private healthcare systems, CUHKMC is dedicated to offering quality healthcare service at affordable and transparent package prices. In line with the not-for-profit principle, all surpluses from all healthcare services will be ploughed back to the hospital for hospital development and the CUHK Faculty of Medicine for research and teaching.  For more details about CUHK Medical Centre, please visit its official website:

Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year.

Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For more information, please visit 

CUHK Medical Centre
Ms Tracy CHUNG

Roche Hong Kong Limited
Ms Iris LAM

© Roche Hong Kong This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.Remark: This statement has been translated into Chinese. In case of inconsistency between the English and Chinese versions, the English version shall prevail.

ContactWorldwidelinkedinfacebooktwitterinstagramyoutubePersonalized healthcareCareersPatient supportPrivacy policyLegal statementPrivacy notice for pharmacovigilance and medical information and product quality